Bifidobacterium lactis HN019

Bifidobacterium lactis HN019 is heavily documented for its impact on gastrointestinal motility and immune function.

Primary Efficacy Data

• Colonic Transit Time (CTT): Dose-dependent reductions in CTT, making it highly effective for occasional constipation. Efficacy seen at 1 Billion to 10 Billion CFU daily.
• Cellular Immunity: Enhances phagocytic activity of mononuclear and polymorphonuclear cells.